Orlando Landrum, MD
Interventional Pain Medicine · Elkhart, INNPI 1932159910
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.5%), other and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by GRT US Holding, Inc. at 51.6% of the total. Reporting peaked in 2022 at $16,044 and has fallen 62.5% since, to $6,020 in 2025. Among interventional pain medicine clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $300.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GRT US Holding, Inc.$18K
- Neuronetics, Inc.$12K
- Acelrx Pharmaceuticals, Inc.$2K
- Abbott$1K
- Genesys Orthopedics Systems, L.L.C.$759
- Boston Scientific$323
- plus $861 from 20 others
What the payments were for
- Consulting fees$17,30051%
- Speaking & faculty fees$4,95014%
- Travel & lodging$2,1426%
- Food & beverage$3,70911%
- Gifts$150%
- Other$6,12218%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GRT US Holding, Inc. | 20 | $17,662 |
| Neuronetics, Inc. | 17 | $11,897 |
| Acelrx Pharmaceuticals, Inc. | 2 | $1,619 |
| Abbott | 15 | $1,117 |
| Genesys Orthopedics Systems, L.L.C. | 4 | $759 |
| Boston Scientific | 9 | $323 |
| Nalu Medical, Inc. | 17 | $211 |
| Nevro Corp. | 4 | $119 |
| Kerecis Limited | 1 | $100 |
| Collegium Pharmaceutical, Inc. | 4 | $64 |
| Stryker | 2 | $51 |
| Spinal Simplicity, LLC | 2 | $40 |
| Globus Medical | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Painteq LLC | 1 | $26 |
| Si-bone, Inc. | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Brainsway USA Inc | 1 | $20 |
| Vertos Medical, Inc. | 1 | $17 |
| Sonex Health, Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$17,393
- NEUROSTAR TMS THERAPY SYSTEM$11,317
- DSUVIA$1,600
- SACROILIAC JOINT FUSION SYSTEM$699
- Proclaim IPG$392
- PROCLAIM$380
- WaveWriter Alpha Prime 16$165
How this compares
$34,238 in reported general payments places this provider in the 95th percentile of 68 interventional pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 14 | $238 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Elkhart
- Jonathan SchrockElkhart$6K
- Christopher AnnisElkhart$4K
- Joshua WellingtonCarmel$315K
- Joseph RutledgeLafayette$96K
- Mahendra SanapatiEvansville$31K
- Nikhil ShettyMunster$29K
- David GordonIndianapolis$28K
- Vinayak BelamkarIndianapolis$28K
- Jocelyn BushIndianapolis$20K
- Scott KimGreenwood$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.